20980683

Tosca L

2011

Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA).

21029608

Shi YH

2010

[Highlights of the sixth national gynecological endocrinology summit of the Chinese Medical Association].

21029609

Li Y

2010

[Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-M?llerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].

21029611

Shi YH

2010

[Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].

21029639

Qu ZY

2010

[Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome].

21034160

Chen JT

2010

Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: a possible monotherapy and a combination therapy after failure with first-line clomiphene citrate.

21036351

Hudecova M

2011

Androgen levels, insulin sensitivity, and early insulin response in women with polycystic ovary syndrome: a long-term follow-up study.

21039282

Ke L

2010

Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome.

21039723

Codner E

2011

Elevated anti-M?llerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus.

21041013

Coskun A

2011

Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.

21044112

Chang AY

2011

Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study.

21050150

Laisk T

2010

Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels.

21050251

Li XJ

2011

Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.

21050810

Peraita-Adrados R

2011

Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.

21050867

Qin K

2011

Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome.

21051133

K???? N

2011

Do threshold values of ovarian volume and follicle number for diagnosing polycystic ovarian syndrome in Turkish women differ from western countries?

21057159

Gutierrez-Grobe Y

2010

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

21059754

Halperin IJ

2011

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.

21062263

Bas D

2011

Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.

21063848

Wang Y

2010

Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications.

21071018

Marquard KL

2011

Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles.

21071192

Deng Y

2011

An automated diagnostic system of polycystic ovary syndrome based on object growing.

21072289

Nahuis M

2010

Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women.

21072999

Macchiarelli G

2010

Morphological expression of angiogenesis in the mammalian ovary as seen by SEM of corrosion casts.

21075366

Zakherah MS

2011

Laparoscopic ovarian drilling in polycystic ovary syndrome: efficacy of adjusted thermal dose based on ovarian volume.

21076799

Chuan SS

2010

Polycystic ovary syndrome and acne.

21077495

Orvieto R

2010

Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in-vitro fertilization cycle.

21077534

Hiei K

2010

Ovarian torsion; early diagnosis by MRI to prevent irreversible damage.

21078264

Wang B

2010

[Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome].

21079574

Ciotta L

2010

[Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome].

21082232

Ranjzad F

2011

Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome.

21082501

Zivi E

2010

Ovarian hyperstimulation syndrome: definition, incidence, and classification.

21082505

Damario MA

2010

Ovarian hyperstimulation syndrome prevention strategies: oral contraceptive pills-dual gonadotropin-releasing hormone agonist suppression with step-down gonadotropin protocols.

21083920

Huang J

2010

Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China.

21084397

Manner?s-Holm L

2011

Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.

21084710

Duval DL

2011

PRKA/AMPK: integrating energy status with fertility in pituitary gonadotrophs.

21085768

Costa EC

2010

[Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome].

21088016

Chen MJ

2011

High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome.

21088474

Cakir E

2011

Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.

21090334

Lai MH

2010

[Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].

21098627

Wijeyaratne CN

2011

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

21105563

Sangraula H

2009

Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.

21105835

Kilic S

2011

Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.

21106494

Kim ST

2011

Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus.

21107589

Sahinkanat T

2011

The relationship between serum testosterone levels and bladder storage symptoms in a female population with polycystic ovary syndrome.

21112021

Nitsche K

2010

Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

21112136

Raja-Khan N

2011

Brachial artery conductance during reactive hyperemia is increased in women with polycystic ovary syndrome.

21113347

Tanmahasamut P

2010

Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature.

21114431

Hossain N

2011

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).

21114583

Abu Hashim H

2011

Combined metformin and clomiphene citrate versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.

21115506

Mumford SL

2011

Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation.

21117302

Rudnicka E

2010

[Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].

21117862

Mancini F

2011

Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis.

21117953

Dujic T

2011

Optimization of high-resolution melting analysis for simultaneous genotyping of two 11?-hydroxysteroid dehydrogenase type 1 gene polymorphisms.

21121941

Franks S

2011

When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?

21122841

Codner E

2011

Ovulation rate in adolescents with type 1 diabetes mellitus.

21123449

Tasali E

2011

Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.

21124696

Weil S

2010

The treatment of women with epilepsy.

21125210

Li L

2011

Association study of +45G15G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome.

21126943

Tarkun I

2010

Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome.

21127151

Safar FH

2011

Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age.

21128379

Stephenson T

2010

PCOS: clinical presentation guides treatment of this multifaceted disease.

21129329

Farhy LS

2010

Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.

21131535

Ledger WL

2010

Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology.

21131540

Legro RS

2010

Metformin during pregnancy in polycystic ovary syndrome: another vitamin bites the dust.

21132313

Zangeneh FZ

2011

The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat.

21134068

Herbert DL

2010

Early users of fertility treatment with hormones and IVF: women who live in major cities and have private health insurance.

21134104

Kumarapeli V

2011

Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women.

21136846

Escobar-Morreale HF

2008

Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome.

21140159

Gode F

2011

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate.

21142777

Galazis N

2011

D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.

21143924

Panidis D

2010

The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study.

21144505

Raja-Khan N

2011

Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.

21144516

El Behery MM

2011

Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3-dimensional power Doppler.

21147223

Mlinar B

2011

Expression of 11?-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.

21148661

Seow KM

2011

Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome.

21151128

Chen ZJ

2011

Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

21151687

Nicholson F

2010

Effectiveness of long-term (twelve months) nonsurgical weight loss interventions for obese women with polycystic ovary syndrome: a systematic review.

21152842

Reis KS

2010

[Anthropometric and metabolic evaluation of first-degree male relatives of women with polycystic ovary syndrome].

21156647

Studen KB

2011

Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome.

21157321

Abrams P

2011

Metabolic effects of obesity causing disease in childhood.

21157477

Kalgaonkar S

2011

Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS.

21158892

Pasquali R

2011

PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

21159854

Roland AV

2011

Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood.

21163039

Chen H

2010

[Effects of body mass index and age on the treatment of in vitro fertilization-embryo transfer among patients with non-polycystic ovarian syndrome].

21164186

Andreassi MG

2011

The association of micronucleus frequency with obesity, diabetes and cardiovascular disease.

21168133

Escobar-Morreale HF

2011

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

21171983

Jones GL

2010

Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study.

21173020

Lazic M

2011

Prenatal androgen treatment alters body composition and glucose homeostasis in male rats.

21173638

Chang RJ

2011

Defining risk in women with polycystic ovary syndrome: a need for constant vigilance.

21173640

Wang ET

2011

Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.

21173657

Dokras A

2011

Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis.

21176559

Song XR

2010

[Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].

21177795

Markopoulos MC

2011

Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.

21178917

Nader S

2010

Infertility and pregnancy in women with polycystic ovary syndrome.

21178921

Chen C

2010

Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

21179569

Gleicher N

2010

FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance.

21188021

Kopera D

2010

Endocrinology of hirsutism.

21188494

Son WY

2011

Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles.

21189149

Lujan ME

2010

Digit ratios by computer-assisted analysis confirm lack of anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.